CA

Calliditas Therapeutics ABSTO Calliditas Therapeutics Stock Report

Last reporting period 30 Jun, 2024

Updated 10 Oct, 2024

Last price

Market cap $B

1.095

Small

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Free cash flow to equity FCFE

-0.011 B

Last period FCFE ,SEK

81%

FCFE has increased in 5 years


What is FCFE ?

Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.

What is FCFE ?

Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.

What is FCFE of Calliditas Therapeutics ?

Calliditas Therapeutics`s FCFE for the period ended 2024-06-30 is -0.011 B SEK

View Full Company Analysis